Literature DB >> 10898695

In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results.

M T García1, C Pelaz, M J Giménez, L Aguilar.   

Abstract

The MICs at which 90% of isolates are inhibited for gemifloxacin, trovafloxacin, and grepafloxacin were low (</=0.01 microg/ml) for 271 Legionella isolates when they were determined by the broth microdilution method but increased (>/=6 dilutions) when they were determined by the agar dilution method. This was due to the charcoal in the agar dilution medium, as shown by the progressive decrease in the MICs when the charcoal concentrations decreased. As free drug is the active fraction, charcoal binding should be considered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898695      PMCID: PMC90033          DOI: 10.1128/AAC.44.8.2176-2178.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.

Authors:  G Ruckdeschel; A Dalhoff
Journal:  J Antimicrob Chemother       Date:  1999-05       Impact factor: 5.790

Review 2.  The treatment of Legionnaires' disease.

Authors:  M Dedicoat; P Venkatesan
Journal:  J Antimicrob Chemother       Date:  1999-06       Impact factor: 5.790

3.  In-vitro activity of antibiotics against Legionella pneumophila isolates from water systems.

Authors:  A Tsakris; S Alexiou-Daniel; E Souliou; A Antoniadis
Journal:  J Antimicrob Chemother       Date:  1999-11       Impact factor: 5.790

Review 4.  Antimicrobial chemotherapy for legionnaires' disease: a review.

Authors:  P H Edelstein
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

5.  WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

6.  The effect of inoculum, culture medium and antimicrobial combinations on the in-vitro susceptibilities of Legionella pneumophila.

Authors:  D J Pohlod; L D Saravolatz; E L Quinn; M M Somerville
Journal:  J Antimicrob Chemother       Date:  1981-04       Impact factor: 5.790

7.  Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organisms.

Authors:  P H Edelstein; K A Pasiecznik; V K Yasui; R D Meyer
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

8.  Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.

Authors:  D M Liebers; A L Baltch; R P Smith; M C Hammer; J V Conroy
Journal:  J Antimicrob Chemother       Date:  1989-01       Impact factor: 5.790

  8 in total
  4 in total

1.  In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.

Authors:  P H Edelstein; T Shinzato; E Doyle; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: first results from Turkey.

Authors:  Haluk Erdogan; Fusun Can; Muge Demirbilek; Funda Timurkaynak; Hande Arslan
Journal:  Environ Monit Assess       Date:  2010-01-05       Impact factor: 2.513

3.  Antimicrobial agent susceptibilities of Legionella pneumophila MLVA-8 genotypes.

Authors:  Yehonatan Sharaby; Orna Nitzan; Ingrid Brettar; Manfred G Höfle; Avi Peretz; Malka Halpern
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

4.  Legionella antimicrobial sensitivity testing: comparison of microbroth dilution with BCYE and LASARUS solid media.

Authors:  Edward Portal; Kirsty Sands; Artjoms Portnojs; Victoria J Chalker; Owen B Spiller
Journal:  J Antimicrob Chemother       Date:  2021-04-13       Impact factor: 5.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.